Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity

Abstract

Recent accumulated evidence suggests that prolactin (PRL) is an important immunomodulator and plays a part in the pathogenesis of systemic lupus erythematosus (SLE). The current study assessed the frequency of hyperprolactinaemia in patients with SLE and its association with defined clinical manifestations or serological abnormalities.

PRL levels were analysed in 60 patients with SLE including a follow-up of 20 patients, 18 patients with rheumatic autoimmune diseases other than SLE (AID) and in 47 normal healthy subjects (NHS) using ELISA. Clinical manifestations and disease activity (ECLAM) were recorded. Autoantibodies (anti-dsDNA, anti-CL) were determined by standard techniques.

In all, 28.3% of the patients with SLE had raised serum PRL. Their PRL levels (17.4 15.1 ng =ml, P < 0.0001) and those of patients with AID (13.1 10.3 ng/ml, P < 0.001) were significantly higher compared to NHS (6.3 3.2 ng =ml). Anti-dsDNA (r_s=0.3, P=0.04) and anti-CL antibody titres (IgG; r_s=0.3, P=0.03) correlated with PRL level. Furthermore, elevated erythrocyte sedimentation rate (ESR), anaemia, decrease in C3, fatigue, fever and renal involvement were associated with hyperprolactinaemia. These results were confirmed by follow-up examinations.

Moderate hyperprolactinaemia is present in a subset of patients with SLE and serum PRL correlates with clinical and serological disease activity.

Keywords

prolactin autoantibodies

Get full access to this article

View all access options for this article.

References

Ben Jonathan N , Mershon JL , Allen DL , Steinmetz RW . Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects . Endocr Rev 1996; 17: 639–669 .

Berczi I , Nagy E , Asa SL , Kovacs K . Pituitary hormones and contact sensitivity in rats . Allergy 1983; 38: 325–330 .

Gutiérrez MA , Molina JF , Jara LJ et al. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals . Int Arch Allergy Immunol 1996; 109: 229–235 .

Lahat N , Miller A , Shtiller R , Touby E . Differential effects of prolactin upon activation and differentiation of human B lymphocytes . J Neuroimmunol 1993; 47: 35–40 .

Nagy E , Berczi I , Friesen HG . Regulation of immunity in rats by lactogenic and growth hormones . Acta Endocrinol (Copenh) 1983; 102: 351–357 .

Nagy E , Berczi I , Wren GE , Asa SL , Kovacs K . Immunomodulation by bromocriptine . Immunopharmacology 1983; 6: 231–243 .

Gutiérrez MA , Molina JF , Jara LJ et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity . Lupus 1995; 4: 348–352 .

Elbourne KB , Keisler D , McMurray RW. Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus . Lupus 1998; 7: 420–427 .

McMurray R , Keisler D , Kanuckel K , Izui S , Walker SE . Prolactin influences autoimmune disease activity in the female B/W mouse . J Immunol 1991; 147: 3780–3787 .

10.

Buskila D , Berezin M , Gur H et al. Autoantibody profile in the sera of women with hyperprolactinemia . J Autoimmun 1995; 8: 415–424 .

11.

Ferrari C , Boghen M , Paracchi A et al. Thyroid autoimmunity in hyperprolactinaemic disorders . Acta Endocrinol (Copenh) 1983; 104: 35–41 .

12.

Krause I , Blumenfeld Z , Malchinsky M et al. Anti-endothelial cell antibodies in the sera of hyperprolactinemic women . Lupus 1998; 7: 377–382 .

13.

Gutiérrez MA , Anaya JM , Scopelitis E , Citera G , Silveira L , Espinoza LR . Hyperprolactinaemia in primary Sjogren's syndrome . Ann Rheum Dis 1994; 53: 425-425 .

14.

Hedner LP , Bynke G . Endogenous iridocyclitis relieved during treatment with bromocriptine . Am J Ophthal 1985; 100: 618–619 .

15.

Honegger J , Fahlbusch R , Bornemann A et al. Lymphocytic and granulomatous hypophysitis: experience with nine cases . Neurosurgery 1997; 40: 713–722 .

16.

Kucharz EJ , Jarczyk R , Jonderko G , Rubisz-Brezezinska J , Brzezinska-Wcislo L . High serum level of prolactin in patients with systemic sclerosis . Clin Rheumatol 1996; 15: 314-314 .

17.

Lever EG , McKerron CG . Auto-immune Addison's disease associated with hyperprolactinaemia . Clin Endocrinol (Oxf) 1984; 21: 451–457 .

18.

Picco P , Gattorno M , Buoncompagni A , Facchetti P , Rossi G , Pistoia V . Prolactin and interleukin 6 in prepubertal girls with juvenile chronic arthritis . J Rheumatol 1998; 25: 347–351 .

19.

Buskila D , Lorber M , Neumann L , Flusser D , Shoenfeld Y . No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus . J Rheumatol 1996; 23: 629–632 .

20.

Huang CM , Chou CT. Hyperprolactinemia in systemic lupus erythematosus . Chung Hua I Hsueh Tsa Chih (Taipei) 1997; 59: 37–41 .

21.

Jara LJ , Gomez-Sanchez C , Silveira LH , Martinez-Osuna P , Vasey FB , Espinoza LR . Hyperprolactinemia in systemic lupus erythematosus: association with disease activity . Am J Med Sci 1992; 303: 222–226 .

22.

Jimena P , Aguirre MA , Lopez-Curbelo A , de Andres M , Garcia-Courtay C , Cuadrado MJ . Prolactin levels in patients with systemic lupus erythematosus: a case controlled study . Lupus 1998; 7: 383–386 .

23.

Lavalle C , Loyo E , Paniagua R et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus . J Rheumatol 1987; 14: 268–272 .

24.

Miranda JM , Prieto RE , Paniagua R et al. Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis . Lupus 1998; 7: 387–391 .

25.

Mok CC , Lau CS , Tam SC . Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients . Br J Rheumatol 1997; 36: 986–989 .

26.

Munoz JA , Gil A , Lopez-Dupla JM , Vazquez JJ , Gonzalez-Gancedo P. Sex hormones in chronic systemic lupus erythematosus. Correlation with clinical and biological parameters . Ann Med Interne (Paris) 1994; 145: 459–463 .

27.

Neidhart M . Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases . J Rheumatol 1996; 23: 476–481 .

28.

Ostendorf B , Fischer R , Santen R , Schmitz-Linneweber B , Specker C , Schneider M . Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 1996; 25: 97–102 .

29.

Pauzner R , Urowitz MB , Gladman DD , Gough JM . Prolactin in systemic lupus erythematosus . J Rheumatol 1994; 21: 2064–2067 .

30.

Alvarez-Nemegyei J , Cobarrubias-Cobos A , Escalante-Triay F , Sosa-Munoz J , Miranda JM , Jara LJ . Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study . Lupus 1998; 7: 414–419 .

31.

McMurray RW , Weidensaul D , Allen SH , Walker SE . Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus . J Rheumatol 1995; 22: 2084–2091 .

32.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthrit Rheum 1982; 25: 1271–1277 .

33.

Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthrit Rheum 1997; 40: 1725-1725 .

34.

Vitali C , Bencivelli W , Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE . Clin Exp Rheumatol 1992; 10: 541–547 .

35.

Spangalo BL , Judd AM , Isakson PC , MacLeod RM . Interleukin-6 stimulates anterior pituitary hormone release in vitro . Endocrinology 1989; 125: 575–577 .

36.

Tsigos C , Papanicolaou DA , Defensor R , Mitsiadis CS , Kyrou I , Chrousos GP . Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure . Neuroendocrinology 1997; 66: 54–62 .

37.

El-Garf , Salah S , Shaarawy M , Zaki S , Anwer S . Prolactin hormone in juvenile systemic lupus erythematosus: a possible relationship to diseaese activity and CNS manifestations . J Rheumatol 1996; 23: 374–377 .

38.

Gutiérrez MA , Anaya JM , Scopelitis E , Citera G , Silveira L , Espinoza LR . Hyperprolactinaemia in primary Sjogren's syndrome . Ann Rheum Dis 1994; 53: 425-425 .

39.

Gutiérrez MA , Garcia ME , Rodriguez JA , Rivero S , Jacobelli S . Hypothalamic–pituitary–adrenal axis function and prolactin secretion in systemic lupus erythematosus . Lupus 1998; 7: 404–408 .

40.

Hattori N , Ikekubo K , Ishihara T , Moridera K , Hino M , Kurahachi H . Correlation of antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody . Eur J Endocrinol 1994; 130: 438–445 .

41.

Hattori N , Inagaki C . Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex . J Clin Endocrinol Metab 1997; 82: 3107–3110 .

42.

Leanos A , Pascoe D , Fraga A , Blanco-Favela F . Anti-prolactin auto antibodies in systemic lupus erythematosus patients with associated hyperprolactinemia . Lupus 1998; 7: 398–403 .

43.

Rovensky J , Jurankova E , Rauova L et al. Relationship between endocrine, immune, and clinical variables in patients with systemic lupus erythematosus . J Rheumatol 1997; 24: 2330–2334 .

44.

Swaak AJ , Groenwold J , Aarden LA , Statius van Eps LW , Feltkamp EW. Prognostic value of anti-dsDNA in SLE . Ann Rheum Dis 1982; 41: 388–395 .

45.

Buttgereit F , Grunewald T , Schuler-Maue W , Burmester GR , Hiepe F . Value of anticardiolipin antibodies for monitoring disease activity in systemic lupus erythematosus and other rheumatic diseases . Clin Rheumatol 1997; 16: 562–569 .

46.

Blanco-Favela F , Quintal-Alvarez G , Leanos-Miranda A . Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power . J Rheumatol 1999; 26: 55– 59 .

47.

Miranda JM , Prieto RE , Paniagua R , Garcia G , Amato D , Barile L , Jara LJ . Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis . Lupus 1998; 7: 387–391 .

48.

Lim VS , Kathpalia SC , Frohman LA . Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation . J Clin Endocrinol Metab 1979; 48: 101–107 .

49.